Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window

The trading window shall remain closed from 01st July 2024 till 48 hours after the declaration of unaudited financial results for the quarter and year ended June 30th 2024
28-06-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Inauguration Of New Center Of Lotus Eye Hospital And Institute Limited At Karur Tamilnadu

We are pleased to inform the opening of 09th center of Lotus Eye Hospital and Institute Limited at Karur Tamil Nadu
12-06-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

The Advertisement of the financial results in The Tamil Hindu (Coimbatore Edition) and Business standard (All India Edition) on 28th May 2024.
28-05-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Financial Results For The Quarter And Year Ended 31St March 2024

The Board of directors of Lotus Eye Hospital and Institute Limited approved the audited financial results for the quarter and financial year ended 31st march 2024
27-05-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Outcome Of Board Meeting Held On 27Th May 2024

The Board of Directors of Lotus Eye Hospital and Institute Limited approved the audited standalone financial results for the quarter and financial year ended 31st March 2024
27-05-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47(1)(d) of SEBI LODR 2015 notice to shareholders
22-05-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 02, 2024 for S Rajkumar
03-05-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyLotus Eye Hospital And Institute Ltd 2CIN NO.L85110TZ1997PLC007783 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M Achuth menon Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Reghunathan Ramanujam Designation: Chief Financial Officer EmailId: [email protected] Date: 20/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
20-04-2024
Bigul

Lotus Eye Hospital And Institute Ltd - 532998 - Certificate Under Regulation 40(9) Of SEBI LODR 2015

Pursuant to Regulation 40(10) we hereby attach the certificate issued by a practicing company secretary under Regulation 40(9) of SEBI LODR 2015
16-04-2024
Next Page
Close

Let's Open Free Demat Account